3 hours Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Given Consensus Recommendation of “Moderate Buy” by Brokerages MarketBeat
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the five research firms that are covering the company, MarketBeat Ratings reports. One equities research analyst has rate…
Nasdaq 100 · Pharmaceuticals · Science